Englewood Lab Inc
Englewood Lab, Inc. engages in the research, development, manufacture, and sale of cosmetic products in the United States, Korea, Canada, China, Japan Europe, and internationally. It offers masks, cleansers, and anti-aging skincare products, as well as face, eye, and body moisturizer; primers and foundations, BB and CC Cream, concealer, blush and illuminizers, bronzer highlighter, and lip care; a… Read more
Englewood Lab Inc (950140) - Net Assets
Latest net assets as of September 2025: ₩154.89 Billion KRW
Based on the latest financial reports, Englewood Lab Inc (950140) has net assets worth ₩154.89 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩230.10 Billion) and total liabilities (₩75.21 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩154.89 Billion |
| % of Total Assets | 67.32% |
| Annual Growth Rate | -46.36% |
| 5-Year Change | 75.55% |
| 10-Year Change | N/A |
| Growth Volatility | 35.03 |
Englewood Lab Inc - Net Assets Trend (2015–2024)
This chart illustrates how Englewood Lab Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Englewood Lab Inc (2015–2024)
The table below shows the annual net assets of Englewood Lab Inc from 2015 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩97.89 Million | +9.83% |
| 2023-12-31 | ₩89.12 Million | +21.41% |
| 2022-12-31 | ₩73.41 Million | +7.50% |
| 2021-12-31 | ₩68.28 Million | +22.46% |
| 2020-12-31 | ₩55.76 Million | +5.62% |
| 2019-12-31 | ₩52.79 Million | +4.10% |
| 2018-12-31 | ₩50.72 Million | -9.93% |
| 2017-12-31 | ₩56.31 Million | -9.04% |
| 2016-12-31 | ₩61.90 Million | -99.77% |
| 2015-12-31 | ₩26.65 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Englewood Lab Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 95.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩44.81 Million | 45.77% |
| Common Stock | ₩4.97 Million | 5.07% |
| Other Components | ₩48.11 Million | 49.15% |
| Total Equity | ₩97.89 Million | 100.00% |
Englewood Lab Inc Competitors by Market Cap
The table below lists competitors of Englewood Lab Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tianjin Songjiang Co Ltd
SHG:600225
|
$60.07 Million |
|
ARRAIL GROUP LTD.
F:I1D
|
$60.09 Million |
|
Granite Falls Energy LLC
PINK:GFGY
|
$60.09 Million |
|
Seoul City Gas
KO:017390
|
$60.10 Million |
|
Mega Uranium Ltd.
PINK:MGAFF
|
$60.05 Million |
|
AIRA Capital Public Company Limited
BK:AIRA
|
$60.05 Million |
|
PRUKSA HOLDING
BK:PSH-R
|
$59.98 Million |
|
SIIC Environment Holdings Ltd
PINK:AWAEF
|
$59.96 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Englewood Lab Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 89,123,720 to 97,887,860, a change of 8,764,140 (9.8%).
- Net income of 14,390,190 contributed positively to equity growth.
- Dividend payments of 1,490,090 reduced retained earnings.
- Other factors decreased equity by 4,135,960.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩14.39 Million | +14.7% |
| Dividends Paid | ₩1.49 Million | -1.52% |
| Other Changes | ₩-4.14 Million | -4.23% |
| Total Change | ₩- | 9.83% |
Book Value vs Market Value Analysis
This analysis compares Englewood Lab Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2569.54x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 3960.57x to 2569.54x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩3.20 | ₩12660.00 | x |
| 2017-12-31 | ₩2.83 | ₩12660.00 | x |
| 2018-12-31 | ₩2.55 | ₩12660.00 | x |
| 2019-12-31 | ₩2.66 | ₩12660.00 | x |
| 2020-12-31 | ₩2.81 | ₩12660.00 | x |
| 2021-12-31 | ₩3.44 | ₩12660.00 | x |
| 2022-12-31 | ₩3.69 | ₩12660.00 | x |
| 2023-12-31 | ₩4.49 | ₩12660.00 | x |
| 2024-12-31 | ₩4.93 | ₩12660.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Englewood Lab Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.70%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.77%
- • Asset Turnover: 0.98x
- • Equity Multiplier: 1.39x
- Recent ROE (14.70%) is above the historical average (8.48%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 49.78% | 9.27% | 3.10x | 1.73x | ₩10.60 Billion |
| 2016 | -0.39% | -0.36% | 0.98x | 1.13x | ₩-6.43 Million |
| 2017 | -21.79% | -15.93% | 0.89x | 1.53x | ₩-17.90 Million |
| 2018 | -10.57% | -4.97% | 1.15x | 1.85x | ₩-10.43 Million |
| 2019 | 3.69% | 1.70% | 1.15x | 1.89x | ₩-3.33 Million |
| 2020 | 4.68% | 2.25% | 1.16x | 1.79x | ₩-2.96 Million |
| 2021 | 19.19% | 9.33% | 1.30x | 1.58x | ₩6.28 Million |
| 2022 | 7.66% | 4.80% | 1.10x | 1.46x | ₩-1.72 Million |
| 2023 | 17.83% | 10.03% | 1.18x | 1.51x | ₩6.98 Million |
| 2024 | 14.70% | 10.77% | 0.98x | 1.39x | ₩4.60 Million |
Industry Comparison
This section compares Englewood Lab Inc's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,255,204,097,239
- Average return on equity (ROE) among peers: 165.42%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Englewood Lab Inc (950140) | ₩154.89 Billion | 49.78% | 0.49x | $60.05 Million |
| Amore Group (002790) | $4.89 Trillion | 5.33% | 0.26x | $733.67 Million |
| Amorepacific Group (002795) | $6.99 Trillion | 3.60% | 0.22x | $333.07 Million |
| Hankook Cosmetics Manufacturing Co Ltd (003350) | $25.45 Billion | -9.21% | 0.59x | $50.11 Million |
| Daelim Trading (006570) | $76.43 Billion | -16.61% | 1.09x | $3.62 Million |
| Monalisa (012690) | $54.46 Billion | 10.90% | 0.28x | $26.00 Million |
| Leaders Cosmetics Co. Ltd (016100) | $63.99 Billion | 24.29% | 0.52x | $13.95 Million |
| Aekyung Industrial Co Ltd (018250) | $333.04 Billion | 3.44% | 0.30x | $78.84 Million |
| Kolmar Holding (024720) | $48.25 Billion | 5.20% | 0.61x | $69.59 Million |
| Jayjun Co Ltd (025620) | $4.96 Billion | 1635.91% | 10.27x | $4.89 Million |
| Coreana Cosmetics Co.Ltd (027050) | $65.95 Billion | -8.68% | 0.74x | $33.77 Million |